Disruption of the ZFP574–THAP12 complex suppresses B cell malignancies in mice
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2409232121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Xue Zhong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390. Hauptthemen laut MEDLINE: B-Lymphocytes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
Despite the availability of life-extending treatments for B cell leukemias and lymphomas, many of these cancers remain incurable. Thus, the development of new molecular targets and therapeutics is needed to expand treatment options. To identify new molecular targets, we used a forward genetic screen in mice to identify genes required for development or survival of lymphocytes. Here, we describe Zfp574 , an essential gene encoding a zinc finger protein necessary for normal and malignant lymphocyte survival. We show that ZFP574 interacts with zinc finger protein THAP12 and promotes the G1-to-S-phase transition during cell cycle progression. Mutation of ZFP574 impairs nuclear localization of the ZFP574–THAP12 complex. ZFP574 or THAP12 deficiency results in cell cycle arrest and impaired lymphoproliferation. Germline mutation, acute gene deletion, or targeted degradation of ZFP574 suppressed Myc-driven B cell leukemia in mice, but normal B cells were largely spared, permitting long-term survival, whereas complete lethality was observed in control animals. Our findings support the identification of drugs targeting ZFP574–THAP12 as a unique strategy to treat B cell malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
- Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
ORCID-Profile: James J Moresco, Ran Song, Eva Marie Y Moresco, Bruce Beutler, Jin Huk Choi
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Zhong, X., Moresco, J. J., SoRelle, J. A., Song, R., Jiang, Y., Nguyen, M. T., Wang, J., Bu, C. H., Moresco, E. M. Y., Beutler, B., & Choi, J. H. (2024). Disruption of the ZFP574–THAP12 complex suppresses B cell malignancies in mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2409232121
Vancouver
Zhong X, Moresco JJ, SoRelle JA, Song R, Jiang Y, Nguyen MT, et al. Disruption of the ZFP574–THAP12 complex suppresses B cell malignancies in mice. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2409232121
BibTeX
@article{Zhong2024,
author = {Zhong, Xue and Moresco, James J and SoRelle, Jeffrey A and Song, Ran and Jiang, Yiao and Nguyen, Mylinh T and Wang, Jianhui and Bu, Chun Hui and Moresco, Eva Marie Y and Beutler, Bruce and Choi, Jin Huk},
title = {Disruption of the ZFP574–THAP12 complex suppresses B cell malignancies in mice},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2409232121}
}
EUVIMED